The Tyro (ASX: TYR) share price jumps 5% on 2 positive updates

The Tyro Payments (ASX: TYR) share price has jumped 5% after the company announced a positive COVID-19 update and a telehealth acquisition.

| More on:
boy in celebration pose with pointed fingers raised high

Image source: Getty Images

The Tyro Payments Ltd (ASX: TYR) share price is lifting after the company announced 2 positive updates today.

At the time of writing, the Tyro share price is trading 5.26% higher at $3.60. 

What’s driving the Tyro share price today? 

COVID-19 trading update 

Tyro has remained committed to providing weekly transaction value updates for greater transparency regarding the impact of COVID-19 on its business. 

In today’s update, the company revealed a 102% date-on-date increase in transaction values between 1 May and 7 May from $0.263 billion to $0.531 billion. From a year-to-date perspective, transaction values have increased 21% from $17.45 billion to $21.12 billion. 

May’s doubling of transaction values likely reflects the cycling of weak COVID-19 driven comparables from a year ago. 

Tyro acquires Medipass 

Alongside the regular COVID-19 trading update, Tyro announced its acquisition of health fintech, Medipass, for $22.5 million. The acquisition’s total consideration is expected to comprise 60% cash and 40% Tyro shares, with the completion set to occur this month. 

Medipass has created a digital health payment platform allowing healthcare providers to accept healthcare payments without the need for a terminal. Its multi-sided platform links healthcare funders, healthcare providers and patients to streamline the claims approval and payment acceptance process. 

Medipass currently integrates with 17 cloud-based practice management and bookings systems, with approximately 4,400 active healthcare providers working with it. 

Tyro believes Medipass’ functionality and clientele complement its existing health vertical and integrated practice management systems. The company will integrate Medipass’s digital health payments platform with Tyro’s card-present health solution to create a unified health payments offering. This solution will deliver both card-present and non-card present transactions. 

Both the COVID-19 trading update and telehealth acquisition appear to be well received by the market, with the Tyro share price making up for lost ground after falling almost 10% last week. 

Management commentary 

Commenting on the acquisition, Tyro CEO and managing director Robbie Cooke said: 

Our combination with Medipass is a significant step in building out Tyro’s core health vertical and is consistent with our strategy to build our offering through acquisition where there is a distinct opportunity to gain scale and to enhance our position in a key vertical.

Making a comeback

Just when things started to get better for the Tyro share price after the initial COVID-19 selloff last year, its business was hit with a significant terminal outage. This, in turn, instigated a scathing short-seller attack from Viceroy Research in January this year. 

Its shares have only recently managed to recoup the losses from those negative events. 

Wondering where you should invest $1,000 right now?

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes could be the five best ASX stocks for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now.

*Returns as of January 12th 2022

Kerry Sun has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of and recommends Tyro Payments. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News